Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1291-1300 of 1,396) with videos related to

Pageof 140
Sort By:
The New England Journal of Medicine|November 7, 2012
Effects of dalcetrapib in patients with a recent acute coronary syndromeGregory G Schwartz, Anders G Olsson, Markus Abt, et al.
Nucleic Acids Research|August 10, 2022
Mammalian RNase H1 directs RNA primer formation for mtDNA replication initiation and is also necessary for mtDNA replication completionJelena Misic, Dusanka Milenkovic, Ali Al-Behadili, et al.
Scientific Reports|May 16, 2019
Vasculogenic properties of adventitial Sca-1<sup>+</sup>CD45<sup>+</sup> progenitor cells in mice: a potential source of vasa vasorum in atherosclerosisDeborah Toledo-Flores, Anna Williamson, Nisha Schwarz, et al.
Clinical Cardiology|August 21, 2018
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trialStephen J Nicholls, A Michael Lincoff, Dianna Bash, et al.
Nature Communications|December 4, 2019
A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansionPeter G Boone, Lauren K Rochelle, Joshua D Ginzel, et al.
JAMA|April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trialSteven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
JAMA Cardiology|May 16, 2021
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH TrialSteven E Nissen, A Michael Lincoff, Kathy Wolski, et al.
JAMA Cardiology|July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical TrialStephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.
NPJ Digital Medicine|May 5, 2022
Evaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorderJonathan T Megerian, Sangeeta Dey, Raun D Melmed, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
Pageof 140

Showing results (1291-1300 of 1,396) with videos related to

Sort By:
Pageof 140
The New England Journal of Medicine|November 7, 2012
Effects of dalcetrapib in patients with a recent acute coronary syndromeGregory G Schwartz, Anders G Olsson, Markus Abt, et al.
Nucleic Acids Research|August 10, 2022
Mammalian RNase H1 directs RNA primer formation for mtDNA replication initiation and is also necessary for mtDNA replication completionJelena Misic, Dusanka Milenkovic, Ali Al-Behadili, et al.
Scientific Reports|May 16, 2019
Vasculogenic properties of adventitial Sca-1<sup>+</sup>CD45<sup>+</sup> progenitor cells in mice: a potential source of vasa vasorum in atherosclerosisDeborah Toledo-Flores, Anna Williamson, Nisha Schwarz, et al.
Clinical Cardiology|August 21, 2018
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trialStephen J Nicholls, A Michael Lincoff, Dianna Bash, et al.
Nature Communications|December 4, 2019
A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansionPeter G Boone, Lauren K Rochelle, Joshua D Ginzel, et al.
JAMA|April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trialSteven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
JAMA Cardiology|May 16, 2021
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH TrialSteven E Nissen, A Michael Lincoff, Kathy Wolski, et al.
JAMA Cardiology|July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical TrialStephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.
NPJ Digital Medicine|May 5, 2022
Evaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorderJonathan T Megerian, Sangeeta Dey, Raun D Melmed, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
Pageof 140